Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the Revision line has changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding operating-status notice from the page; the content now presents only the study details without that disclaimer.SummaryDifference0.2%

- Check42 days agoChange DetectedThere are no significant changes to core study information between screenshots; the page content remains the same and any differences are limited to minor formatting or collapsed sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference2%

- Check78 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with updated versioning rather than new substantive information in the deleted areas.SummaryDifference0.2%

- Check92 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element. This appears to be a minor update with no evident changes to core content, pricing, stock, or time slot information.SummaryDifference0.1%

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.